Howard S. Höchster

机构：Rutgers, The State University of New Jersey, Rutgers Cancer Institute · ORCID：0000-0002-9893-1529

发表论文 583 篇 · 总被引 24786 次 · h-index 72

代表论文

• NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal (2026 · Journal of Clinical Oncology · 被引 5)
• Social vulnerability and clinical trial enrollment: the next frontier of health equity (2025 · JNCI Journal of the National Cancer Institute · 被引 4)
• Data from: Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer (2025 · DRYAD · 被引 1)
• COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer (2026 · Journal of Clinical Oncology)
• Author response: Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer (2025)
• Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer (2025 · eLife)